Wednesday, October 9, 2013

Botox Cosmetic Approved By FDA For New Anti-Aging Usage

by Brian Gaps

On September 11, 2013, the U.S. Food and Drug Administration approved Botox Cosmetic (onabotulinumtoxinA) for use in the reduction of crow's feet. It is currently the only drug treatment approved by the FDA for this usage.

Since 2002, Botox Cosmetic has been approved for the temporary improvement of frown lines between the eyebrows.

“This additional indication will provide people with a new FDA approved treatment option for those seeking a smoother appearance by temporarily minimizing the appearance of crow’s feet at the sides of the eyes,” said Susan Walker, M.D., director of the Division of Dermatology and Dental Products in the FDA’s Center for Drug Evaluation and Research. 

Botox Cosmetic is administered via intramuscular injections. Treatment for both frown lines and crow’s feet can be given at the same time.

Botox Cosmetic is manufactured by Allergan Inc. based in Irvine, Calif.

This information was extracted from an FDA press release:

No comments:

Post a Comment